{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:33:28Z","timestamp":1794447208588,"version":"4.9.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T00:00:00Z","timestamp":1333324800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0031954","type":"journal-article","created":{"date-parts":[[2012,4,2]],"date-time":"2012-04-02T17:06:13Z","timestamp":1333386373000},"page":"e31954","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Low Lipoprotein(a) Concentration Is Associated with Cancer and All-Cause Deaths: A Population-Based Cohort Study (The JMS Cohort Study)"],"prefix":"10.1371","volume":"7","author":[{"given":"Motoji","family":"Sawabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko Naka","family":"Mieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizukiyo","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Kayaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"J. M. S. Cohort Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.","volume":"102","author":"J Danesh","year":"2000","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/STROKEAHA.106.480657","article-title":"Lipoprotein (a) and stroke: a meta-analysis of observational studies.","volume":"38","author":"B Smolders","year":"2007","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status.","volume":"31","author":"BG Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1136\/hrt.2008.160879","article-title":"High lipoprotein(a) level promotes both coronary atherosclerosis and myocardial infarction: a path analysis using a large number of autopsy cases.","volume":"95","author":"M Sawabe","year":"2009","journal-title":"Heart"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ncpcardio1456","article-title":"Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events.","volume":"6","author":"BR Jaeger","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2010.10.052","article-title":"Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice.","volume":"57","author":"E Merki","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2174\/138161211795428777","article-title":"Lipoprotein(a): medical treatment options for an elusive molecule.","volume":"17","author":"KG Parhofer","year":"2011","journal-title":"Curr Pharm Des"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcb.20480","article-title":"Angiostatin&apos;s molecular mechanism: aspects of specificity and regulation elucidated.","volume":"96","author":"ML Wahl","year":"2005","journal-title":"J Cell Biochem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/annonc\/mdj055","article-title":"Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University.","volume":"17","author":"A Kurup","year":"2006","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ctrv.2007.02.006","article-title":"Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency.","volume":"33","author":"G Lippi","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M301042200","article-title":"Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).","volume":"278","author":"JS Kim","year":"2003","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21149","article-title":"Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice.","volume":"43","author":"K Lee","year":"2006","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jgm.638","article-title":"Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination.","volume":"7","author":"HK Yu","year":"2005","journal-title":"J Gene Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1158\/0008-5472.CAN-04-0364","article-title":"Suppression of colorectal cancer liver metastasis and extension of survival by expression of apolipoprotein(a) kringles.","volume":"64","author":"HK Yu","year":"2004","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1006\/bbrc.1999.0519","article-title":"Apolipoprotein(a), a link between atherosclerosis and tumor angiogenesis.","volume":"257","author":"VN Trieu","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ijc.24027","article-title":"A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.","volume":"124","author":"ZF Yi","year":"2009","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ijc.2910430212","article-title":"Elevated apolipoprotein(a) levels in cancer patients.","volume":"43","author":"LC Wright","year":"1989","journal-title":"Int J Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3109\/00365519409088568","article-title":"The behaviour of lipoprotein(a) in patients with various diseases.","volume":"54","author":"JW Van Wersch","year":"1994","journal-title":"Scand J Clin Lab Invest"},{"key":"ref19","first-page":"452","article-title":"Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer.","volume":"47","author":"HH Yang","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"ref20","first-page":"133","article-title":"Elevated serum Lp(a) levels in the early and advanced stages of breast cancer.","volume":"14","author":"E K\u00f6ko\u011flu","year":"1994","journal-title":"Cancer Biochem Biophys"},{"key":"ref21","first-page":"301","article-title":"Lipoprotein (a) behaviour in patients with hepatocellular carcinoma.","volume":"92","author":"M Motta","year":"2001","journal-title":"Minerva Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1023\/B:DDAS.0000030099.13397.28","article-title":"Hypercoagulable states in patients with hepatocellular carcinoma.","volume":"49","author":"DN Samonakis","year":"2004","journal-title":"Dig Dis Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/clinchem\/42.8.1176","article-title":"Effects of androgen suppression by gonadotropin-releasing hormone agonist and flutamide on lipid metabolism in men with prostate cancer: focus on lipoprotein(a).","volume":"42","author":"L Denti","year":"1996","journal-title":"Clin Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ijc.2910520302","article-title":"Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian disease.","volume":"52","author":"AC Kuesel","year":"1992","journal-title":"Int J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<379::AID-CNCR24>3.0.CO;2-P","article-title":"Blood lipid profiles in children with acute lymphoblastic leukemia.","volume":"83","author":"JM Halton","year":"1998","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2188\/jea.12.408","article-title":"The Jichi Medical School (JMS) Cohort Study: design, baseline data and standardized mortality ratios.","volume":"12","author":"S Ishikawa","year":"2002","journal-title":"J Epidemiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/oxfordjournals.aje.a117516","article-title":"Lipoprotein(a) levels in the Japanese population: influence of age and sex, and relation to atherosclerotic risk factors. The Jichi Medical School Cohort Study.","volume":"141","author":"N Nago","year":"1995","journal-title":"Am J Epidemiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2188\/jea.9.32","article-title":"Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.","volume":"9","author":"S Ishikawa","year":"1999","journal-title":"J Epidemiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines.","volume":"8","author":"S Durrleman","year":"1989","journal-title":"Stat Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk.","volume":"16","author":"RJ Gray","year":"1988","journal-title":"Ann Statist"},{"key":"ref31","first-page":"196","article-title":"A proportional hazards model for subdistribution of a competing risk.","volume":"94","author":"JP Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa001066","article-title":"Lp(a) lipoprotein, vascular disease, and mortality in the elderly.","volume":"349","author":"AA Ariyo","year":"2003","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.","volume":"302","author":"S Erqou","year":"2009","journal-title":"Jama"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1373\/clinchem.2007.090969","article-title":"Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study.","volume":"54","author":"KL Chien","year":"2008","journal-title":"Clin Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1046\/j.1532-5415.2001.4911234.x","article-title":"Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status.","volume":"49","author":"Y Arai","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(97)00290-6","article-title":"In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians.","volume":"137","author":"G Pepe","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0021-9150(97)00217-7","article-title":"Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians.","volume":"136","author":"J Thillet","year":"1998","journal-title":"Atherosclerosis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1111\/j.1447-0594.2004.00194.x","article-title":"Tokyo Centenarian Study: Aging inflammation hypothesis.","volume":"4","author":"N Hirose","year":"2004","journal-title":"Geriatrics & Gerontology International"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0009-3084(94)90164-3","article-title":"Lp(a): an acute-phase reactant?","volume":"67-68","author":"A Noma","year":"1994","journal-title":"Chem Phys Lipids"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840120409","article-title":"Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.","volume":"12","author":"K Kiyosawa","year":"1990","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.hepres.2005.04.005","article-title":"Report of the 16th follow-up survey of primary liver cancer.","volume":"32","author":"I Ikai","year":"2005","journal-title":"Hepatol Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/002215549704500408","article-title":"Immunolocalization of lipoprotein(a) in wounded tissues.","volume":"45","author":"Y Yano","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/qjmed\/93.2.75","article-title":"Lipoprotein(a): from ancestral benefit to modern pathogen?","volume":"93","author":"G Lippi","year":"2000","journal-title":"Qjm"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3181\/0804-RM-136","article-title":"A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response.","volume":"234","author":"J Hoover-Plow","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00019501-200603000-00010","article-title":"Serum level of lipoprotein (a) is inversely associated with the development of coronary collateral circulation.","volume":"17","author":"D Aras","year":"2006","journal-title":"Coron Artery Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.0000222666.21482.b6","article-title":"Lipoprotein(a) and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.","volume":"37","author":"T Ohira","year":"2006","journal-title":"Stroke"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1172\/JCI117263","article-title":"Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common &quot;null&quot; allele at the apo(a) locus.","volume":"93","author":"A Gaw","year":"1994","journal-title":"J Clin Invest"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.CIR.87.4.1135","article-title":"Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.","volume":"87","author":"JL Jenner","year":"1993","journal-title":"Circulation"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","article-title":"Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.","volume":"168","author":"A Bennet","year":"2008","journal-title":"Arch Intern Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0031954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T02:24:51Z","timestamp":1593915891000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0031954"}},"subtitle":[],"editor":[{"given":"German","family":"Malaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,2]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0031954","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.g001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.g002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.t001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.t002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s002","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s003","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s004","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s005","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s006","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s007","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1371\/journal.pone.0031954.s008","asserted-by":"subject"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,2]]}}}